Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
JNJ Johnson & Johnson weekly Stock Chart
JNJ [NYSE]
Johnson & Johnson
Healthcare | Drug Manufacturers - Major | USA
financial highlights | statements
IndexDJIA S&P500 P/E24.13 EPS (ttm)5.40 Insider Own0.07% Shs Outstand2.68B Perf Week-2.97%
Market Cap348.70B Forward P/E14.24 EPS next Y9.15 Insider Trans0.17% Shs Float2.65B Perf Month-7.22%
Income14.68B PEG3.72 EPS next Q2.44 Inst Own69.40% Short Float0.53% Perf Quarter-5.24%
Sales81.59B P/S4.27 EPS this Y7.60% Inst Trans-0.07% Short Ratio2.01 Perf Half Y0.95%
Book/sh22.16 P/B5.88 EPS next Y6.42% ROA9.60% Target Price149.17 Perf Year1.96%
Cash/sh5.73 P/C22.74 EPS next 5Y6.48% ROE23.80% 52W Range121.00 - 148.99 Perf YTD0.98%
Dividend3.80 P/FCF39.48 EPS past 5Y3.10% ROI17.00% 52W High-12.54% Beta0.69
Dividend %2.92% Quick Ratio1.10 Sales past 5Y2.70% Gross Margin66.90% 52W Low7.69% ATR2.18
Employees135100 Current Ratio1.40 Sales Q/Q0.10% Oper. Margin20.80% RSI (14)28.46 Volatility1.47% 1.52%
OptionableYes Debt/Eq0.50 EPS Q/Q-13.00% Profit Margin18.00% Rel Volume1.17 Prev Close132.07
ShortableYes LT Debt/Eq0.47 EarningsJul 16 BMO Payout65.60% Avg Volume7.04M Price130.31
Recom2.30 SMA20-6.41% SMA50-5.73% SMA200-5.13% Volume8,230,764 Change-1.33%
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-19-19 10:50PM  JOHNSON & JOHNSON INVESTIGATION UPDATE by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Johnson & Johnson - JNJ Business Wire
05:00PM  Edited Transcript of JNJ earnings conference call or presentation 16-Jul-19 12:30pm GMT Thomson Reuters StreetEvents
11:06AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific Zacks
10:23AM  Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts Benzinga
09:53AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus Zacks
08:56AM  Dow 30 Stock Roundup: MSFT, JPM, IBM, JNJ, GS Earnings Impress Zacks
Jul-18-19 05:23PM  3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement Zacks
03:01PM  Jim Cramer: Looking for Netflix Action? Don't Be a Hero TheStreet.com
01:33PM  Top Stock Reports for Johnson & Johnson, NextEra & Deere Zacks
09:41AM  5 Signs of Life in Johnson & Johnson's Second-Quarter Earnings Report Motley Fool
Jul-17-19 04:19PM  These 4 Medical Stocks Could Benefit From J&J Earnings Here's Why Investor's Business Daily
01:33PM  FlexShares Makes A Big Low Vol ETF Splash Benzinga
01:24PM  After Earnings Beat, Wall Street Talks Johnson & Johnson Litigation Risk Benzinga
10:50AM  Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat Zacks
09:30AM  Company News for Jul 17, 2019 Zacks
03:49AM  WHO declares emergency over Ebola epidemic in Congo Financial Times
Jul-16-19 11:45PM  Opioid makers dumped 76 billion pills onto U.S. market over 7 critical years, data shows MarketWatch
04:40PM  Johnson & Johnson Registers 2nd-Quarter Earnings Beat GuruFocus.com
04:31PM  Here's Why J&J Stock Is Sliding Despite A Second-Quarter Beat Investor's Business Daily
04:28PM  US STOCKS-Wall Street slips as bank earnings, Trump trade comments weigh Reuters
04:17PM  Dow Jones Today: Earnings Disappointments InvestorPlace
03:29PM  US STOCKS-S&P 500 edges lower after mixed bank earnings, Trump comments Reuters
03:23PM  Johnson & Johnson (JNJ) Q2 2019 Earnings Call Transcript Motley Fool
02:55PM  J&J Ups Sales Forecast as Cancer Drugs Drive Growth Bloomberg
02:44PM  Stocks slip after Trump says a long way to go on trade and investors digest bank earnings MarketWatch
02:27PM  J&J stock falls despite earnings beat and guidance boost MarketWatch
02:02PM  Johnson & Johnson Is A Massive Pharma Stock But Should You Buy It? Investor's Business Daily
01:52PM  US Stocks Little Moved as Earnings Roll In Tuesday GuruFocus.com
01:51PM  US STOCKS-Wall Street edges lower after mixed bank earnings, Trump comments Reuters
01:17PM  Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance InvestorPlace
12:51PM  Johnson & Johnson Jumps on Earnings Beat GuruFocus.com
11:13AM  UPDATE 2-Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook Reuters
11:04AM  AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio Zacks
10:33AM  US STOCKS-Wall Street muted after mixed bank earnings Reuters
10:32AM  Better-Than Expected Retail Sales in June Zacks
10:23AM  J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View Zacks
10:14AM  Dow Jones Leads Stock Market Action, As Three Blue Chip Stocks Report Earnings Investor's Business Daily
10:09AM  Retail Sales Up, Import Prices Down, Q2 Earnings Solid Zacks
10:06AM  Mostly Strong Results For Big Banks, And J&J Another Solid Earnings Performer Benzinga
09:54AM  Goldman's stock rally helps keep Dow positive MarketWatch
09:45AM  US STOCKS-Futures flat after JPMorgan results; Goldman Sachs, Wells Fargo eyed Reuters
09:41AM  Stocks Open Lower As Dow Jones Stocks Goldman, J&J and JPMorgan Report Investor's Business Daily
09:37AM  Stocks pull back from record levels as earnings season picks up steam MarketWatch
09:13AM  US STOCKS-Wall Street set for subdued open after mixed bank reports Reuters
08:46AM  Johnson & Johnsons Earnings Beat Estimates, but the Stock Isnt Taking Off Barrons.com
07:56AM  Dow Jones Futures: Facebook Libra Unites Washington; Dow Stocks JPMorgan, Goldman Sachs, J&J Report Investor's Business Daily
07:55AM  Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates Zacks
07:07AM  Shares of J&J up 0.8% after earnings and revenue beat MarketWatch
06:52AM  Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook Reuters
06:40AM  Johnson & Johnson Reports 2019 Second-Quarter Results PR Newswire
06:30AM  Johnson & Johnson to Host Earnings Call ACCESSWIRE
06:06AM  The 2 Safest Dividend Stocks on the Planet Motley Fool
03:26AM  [video]Johnson & Johnson Tops Q2 Earnings Estimate, Boosts 2019 Sales Forecast TheStreet.com
Jul-15-19 05:59PM  J&J Submits BLA for Subcutaneous Formulation of Darzalex Zacks
05:43PM  AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes Zacks
02:44PM  Citigroup, Johnson & Johnson, IBM, and More Stocks to Watch This Week Barrons.com
02:37PM  Johnson & Johnson Q2 Earnings Outlook Benzinga
02:10PM  These Stocks Are Unlike The Others; Can You Profit From Them? Investor's Business Daily
01:28PM  UPDATE 4-Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end Reuters
01:00PM  Bull Signal Sounds for Johnson & Johnson Stock Before Earnings Schaeffer's Investment Research
11:25AM  Dow ETF Appears Strong Ahead of Q2 Earnings Zacks
11:07AM  CORRECTED-UPDATE 2-Oklahoma at trial's end says opioid 'kingpin' J&J fueled epidemic Reuters
10:58AM  Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2019 PR Newswire
10:31AM  Why Johnson & Johnson (JNJ) Might Surprise This Earnings Season Zacks
10:24AM  Earnings Season Starts With Beat From Citigroup; Other Banks, Netflix Report Later In Week Benzinga
09:31AM  Company News for Jul 15, 2019 Zacks
09:24AM  Mondays Vital Data: Johnson & Johnson, Ford and Square InvestorPlace
09:11AM  Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results InvestorPlace
09:05AM  J&J Falls Amid Reports of Criminal Probe Into Talcum Powder Zacks
08:28AM  J&J Reports Earnings Under a Cloud of Baby Powder TheStreet.com
08:18AM  Earnings Watch: Expect drama in second-quarter numbers as trade fears weigh MarketWatch
07:26AM  J&J earnings preview: Wall Street is still optimistic despite companys legal issues MarketWatch
06:35AM  Corrected: Oklahoma at trial's end says opioid 'kingpin' J&J fueled epidemic Reuters
06:07AM  Oklahoma, J&J to wrap up first trial over opioid crisis Reuters
06:00AM  Johnson & Johnson Is Reporting Its Earnings on Tuesday. Heres What To Expect. Barrons.com
Jul-14-19 03:00PM  Should investors prepare for a shock and awe campaign from the Fed? MarketWatch
09:21AM  3 Dow Leaders with Double-Digit Upside TipRanks
Jul-13-19 05:04PM  The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings Benzinga
06:00AM  The Week Ahead: Earnings Season Heats Up Morningstar
Jul-12-19 05:28PM  Here's Why Johnson & Johnson Dropped 4% Today Motley Fool
04:31PM  Dow Jones Today: A Fantastic Friday InvestorPlace
04:26PM  J&J Stock Dives As Feds Reportedly Seek Criminal Probe Into Talc Powders Investor's Business Daily
04:24PM  US STOCKS-Wall St notches all-time highs on lingering rate-cut optimism Reuters
04:16PM  4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB InvestorPlace
04:07PM  J&J Denials of Asbestos in Baby Powder Spur Criminal Probe Bloomberg
03:46PM  4 Healthcare Stocks That Are Feeling Sick InvestorPlace
03:41PM  J&J Draws U.S. DOJ Probe on Talcum Powder Asbestos Denials Bloomberg
03:34PM  Johnson & Johnson Baby Powder News: JNJ Stock Drops on Investigation InvestorPlace
02:47PM  Johnson & Johnson Falls On Report Of Justice Department Probe Benzinga
02:46PM  US STOCKS-Wall Street hits new highs on rate-cut optimism Reuters
02:06PM  J&J faces U.S. criminal probe related to baby powder - Bloomberg Reuters
01:10PM  Johnson & Johnson stock dives 4.3% after Bloomberg reports that DOJ is pursuing criminal investigation into company MarketWatch
12:59PM  Johnson & Johnson Stock Drops on Baby Powder Report Barrons.com
12:35PM  J&J faces U.S. criminal probe related to baby powder - Bloomberg Reuters
12:31PM  Johnson & Johnson faces criminal probe related to baby powder: Bloomberg Reuters
11:14AM  Johnson & Johnson to test experimental HIV vaccine in U.S., Europe Reuters
11:01AM  Why Earnings Season Could Be Great for Johnson & Johnson (JNJ) Zacks
10:19AM  Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug Benzinga
09:20AM  J&J Stock Sinks as Feds Probe Baby Powder Cancer Allegations TheStreet.com
09:19AM  Dow 30 Stock Roundup: Cisco to Buy Acacia, Microsoft & ServiceNow Partnernership Zacks
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
open in yahoo | open in reuters | open in google